Pemetrexed is an antifolate antimetabolite chemotherapy agent used in the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer. It exerts its therapeutic effect by inhibiting… Read more


















































Pemetrexed is an antifolate antimetabolite chemotherapy agent used in the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer. It exerts its therapeutic effect by inhibiting folate-dependent enzymes, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase, which are critical for DNA and RNA synthesis. Within this category, researchers and pharmaceutical laboratories find an extensive range of high-quality reference standards, including Pemetrexed impurities, synthetic intermediates, and degradation products. These materials are essential for rigorous analytical testing, enabling precise impurity profiling and the validation of analytical methods during quality control and batch release procedures. Additionally, the availability of stable isotope labelled compounds provides the necessary precision for quantitative mass spectrometry studies. By utilizing these specialized standards, laboratories can ensure the consistency of their drug products and maintain compliance with international regulatory frameworks throughout the pharmaceutical development and manufacturing process.